Findings from the LEAP2MONO study support the regulatory submission of venglustat for treatment of type 3 Gaucher disease.
Paul McNeill, P.Geo., VP Exploration of NexGold, is considered a “Qualified Person” for the purposes of National Instrument ...
As AI becomes embedded in finance operations, especially through agentic systems that act on behalf of organizations, the ...
The Schools’ Entrance Assessment Group (SEAG) test took place in November 2025 ...
OilPrice.com on MSN
Why Greenland Matters Even If Its Resources Don't Pay
Greenland's immense oil and mineral resources are difficult and expensive to extract, making its strategic geostrategic ...
Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains") is pleased to announce that crews have been mobilized to complete a 1650m, three-hole diamond drilling program at its 100% ...
NexGold Mining Corp. TSXV: NEXG; OTCQX: NXGCF) ("NexGold" or the "Company") is pleased to provide initial results from the ...
Former Artsakh official reveals gaps in Armenia’s housing assistance, with most refugees forced into the expensive secondhand ...
Under the patronage of His Highness Sheikh Dr. Sultan bin Muhammad Al Qasimi, Supreme Council Member and Ruler of Sharjah, ...
Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...
Emirates News Agency on MSN
Sharjah Education Summit welcomes 120 global speakers
SHARJAH, 2nd February, 2026 (WAM) -- Under the patronage of His Highness Sheikh Dr. Sultan bin Muhammad Al Qasimi, Supreme Council Member and Ruler of Sharjah, the 5th Sharjah International Summit on ...
How nutrition therapy supports recovery, rehabilitation, and quality of life in patients with chronic critical illness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results